Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements View External Link Categories Peer Reviewed Publications Topics: BCL6 CD10 diffuse large B-cell lymphoma DLBCL COO immuno-oncology agents IRF4 MUM1 targeted therapeutics